1.
Rezza G, Cereda D, Rizzo C, Cuciniello R, Carole D'Amelio A, Villani A, et al. Nirsevimab: a change of paradigm in the prophylaxis of Respiratory Syncytial Virus disease among infants. Ann Ig [Internet]. 2025 Jun. 12 [cited 2026 Jan. 30];37(5):684-8. Available from: https://mattioli1885journals.com/index.php/annali-igiene/article/view/17453